Maximize NIH and DOD Funding

The FreeMind Group is the premier international consulting firm specializing in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations

ABOUT US

The FreeMind Group turns non-dilutive funding into a strategic source of funding for life science organizations

Meet us at an upcoming event:

All Upcoming Events →


 
 
 

Experience

Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. Our goal is to assist in maximizing potential to receive funding from non-dilutive sources. We have experience in seeking funding from nearly all NIH Institutes, Department of Defense, NSF, FDA, BARDA, etc., as well as private foundations.

Expertise

FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our expertise in applying for grants and contracts extends throughout every government mechanism as well as private foundations open to funding the life sciences.

Success

FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.

Leadership

Ram May-Ron
Ram May-Ron
Managing Partner
Ayal Ronen, M.Sc., MBA
Ayal Ronen, M.Sc., MBA
Vice President
Guy Har-Chen, M.Sc., MBA
Guy Har-Chen, M.Sc., MBA
Chief Analyst
Joel Knopf, M.Sc., MBA
Joel Knopf, M.Sc., MBA
Manager of Consulting Services
Sigal Katz, Ph.D.
Sigal Katz, Ph.D.
Senior Analyst
Inna Grodzovski, Ph.D.
Inna Grodzovski, Ph.D.
Senior Analyst
Amit Sadeh, Ph.D.
Amit Sadeh, Ph.D.
Senior Analyst
Ariel Shatz
Ariel Shatz
Executive Vice President

Strategic Partners

  • onemedplace
  • ebd-group
  • ibf
  • sachs_lge
  • elsevier
  • advamed
  • wbr
  • OBN
  • LSN Logo
  • IIR
  • Biotech and Money
  • biotech-logo
  • FreeMind did unbelievable job- and put in so many hrs today and all throughout the past few weeks. I don’t think we could have done it without such help from FreeMind and all of you!

    Nalini Motwani, Ph.D. - President, BioSavita
  • Many thanks for your excellent support. It was and continues to be our pleasure working with you, and we too look forward to embarking on a new grant project with you again soon.

    Maurits W. Geerlings - Formula Pharmaceuticals
  • Thank you all for your tireless, persistent efforts in pushing this through. We are now well positioned to let the considerable merits of our application shine through. Much appreciated.

    Jonathan Lim - IGNYTA
  • From the Immusoft, Thank you again for your efforts and guidance during the assemblage of our SBIR grant. We have improved our grantsmanship as a result of FMG’s involvement.

    Zach Hall – Immusoft
  • There is no way we would have been able to do it in such a short time without you.
    Thank you for all your help!!!

    Rudy Rodriguez - Advanced Animal Diagnostics
  • After a powerful joint effort as usual, and many careful iterations of edits, this proposal looks top-notch! Thanks to all for your participation in the success of this submission. Thank you Freemind, in particular, your hard work has greatly improved this proposal, you have been a tremendous help, right up to the end.

    Aileen Gibbons - Respira Therapeutics, Inc.
  • Thank you very much. Writing this grant proposal has been very insightful to me, and the Freemind team made it a very smooth process.

    Ed Buurman – Astrazeneca
  • I LOVE working with you guys!! ……..Your true entrepreneurial approach is just what I needed right now…….

    Tim Bertram, Tengion
  • FreeMind has added a lot of value to the proposal, driving us perfectly through the process, the exact role we were expecting

    Luis Ruiz-Avila - Janus Developements
  • We are very satisfied with the role and involvement of FreeMind on our project. All has been submitted on time with a great interaction (and hard work) between our two teams.

    Eric Massou, Poxel
  • Thanks so much for all of your help on this proposal!  I am so grateful that you were available to work with us, and I don’t think we could have done it without you.

    Meghan Norvell, nanoMR
  • You did a fantastic job for Embolx and I continue to recommend FreeMind to entrepreneurs here is Silicon Valley.

    Michael Allen - President and CEO, Embolx

Services at a Glance

Core Services:

  1. STRATEGIC ASSESSMENT – Identification and strategy as to applicable funding sources
  2. GRANT PRODUCTION PROCESS – Maximizing chances for award utilizing a proven strategic approach

 

FreeMind’s professional staff has assisted in attaining funding for R&D activities from all available sources and mechanisms stemming primarily from the National Institutes of Health (NIH) and Department of Defense (DoD).

 

We have helped organizations across the life sciences secure funding from these zero-equity sources. We have worked with many academic institutions, as well as industry members from small start-ups through large pharmaceutical companies.

 

 

Large Scale Funding

Multidisciplinary grants and contracts available for pre-clinical as well as clinical stage research with budgets of $10 million – $150 million per project.

🎯
Targeted Solicitations

UO1s, BAAs, RFPs implemented science and developmental awards with budgets of $3 million – $7 million per project.

💼
SBIR/STTR Grants

Small Business Research and Development grants can be budgeted $150,000 for SBIR/STTR Phase I awards and up to $2 million  for SBIR/STTR Phase II awards.

🏆
R21s and R01s

Basic research, preclinical, and unsolicited grants focusing on early as well as late-stage preclinical research and can be budgeted $1 million – $3 million per project.

The Process

🔍

STRATEGIC ASSESSMENT

Provides a robust, long-term, multi-submission granting strategy for each pipeline project. FreeMind is well versed in the interests, goals, and available funding opportunities of each funding source.

 

MACRO APPLICATION STRATEGY

Outline the specific aims, scope of work, budgetary needs, as well as delineate any collaborators, subcontractors, and consultants required. We devise a timeline to submission and set an orderly division of responsibilities.

GRANT PRODUCTION PROCESS

A combined writing effort, based on comprehensive templates drafted by project managers, yields the work product. The iterative review concludes when a well-structured scientifically sound application materializes.

SUBMISSION AND FOLLOWUP

Upon completion, the application is submitted. Post-submission we closely monitor the review process, and assist with pre-award negotiations, awaiting a final decision by the granting agency.

FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award

Blog

LEARN

Non Dilutive Funding – Non di-lu’-tive Fund-ing

1. funding – financial resources provided to make some project possible; “The National Institute of Health (NIH) provided support for the experiment.”

2. non-dilutive funding – the act of financing R&D activity not traded for public securities and/or shares of a commercial entity; “The FreeMind Group assisted in securing non-dilutive funding from the Department of Defense for a Phase II clinical trial.”

Free Educational Webinars

Listen to FreeMind experts and learn about non-dilutive sources of funding relevant to you.

Participation is FREE of Charge, Registration is Required

Webinars

Upcoming Webinars

February 24, 2016

Watch Online!

Introduction to SBIR and STTR Funding Opportunities

more information

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we will discuss process for applying, guidelines, key success components and insight into increasing chances for award.

March 16, 2016

Watch Online!

Funding Opportunities for Clinical Stage Research

more information

Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences.

Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from the DOD.

In this webinar we will discuss process for applying, guidelines, key success components and insight into increasing chances for award.

April 13, 2016

Watch Online!

Introduction to the DOD’s Congressionally Directed Medical Research Programs (CDMRP)

more information

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military.

With a FY2016 budget of over $800 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer and Multiple Sclerosis. There are several additional Peer Reviewed topics such as Alzheimer’s and Cancer, and others.

In this webinar we will discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.

May 18, 2016

Register Now!

Funding Opportunities for Pre-Clinical Stage Research

more information

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences.

Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private foundations. The NIH alone annually funds over $15B to pre-clinical stage R&D in the life sciences.

In this webinar we will the discuss process for applying, guidelines, key success components and insight into increasing chances for award.

The webinars are designed for first timers as well as seasoned grantees. FreeMind experts will share their insight into various areas of interest as they relate to non-dilutive sources of funding and how to maximize chances for award.

For any inquiries, please email Irina Rajkovetsky: Send Mail

💻

All Webinars are recorded and posted on the FreeMind Group Educational YouTube Channel

JOIN A WEBINAR

FreeMind’s knowledgeable team of expert grant writers share their wisdom on how to maximize chances for award.

Join our mailing list by typing in your email address here:

* Don’t worry, we hate spam as much as you do.

imac

Get in touch with us

For any inquiry or question please contact us by phone or email.

US Office

FreeMind Group
423 Brookline Ave. #124
Boston, MA 02215

Tel: (617) 648-0340
Fax: (617) 904-1767

International Office

FreeMind Group
Hi – Tech Center
Hebrew University
Jerusalem 95702 Israel

Tel: +972 (0)2-6799833
Fax: +972 (0)2-6799834

Contact us using this form


Blog Categories

Join our Mailing List

* Don't worry, we hate spam as much as you do.
Contact us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Questions, issues or concerns? I'd love to help you!

Click ENTER to chat